Arcutis Biotherapeutics (ARQT.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec26

Mizuho Maintains Buy Rating on Arcutis Biotherapeutics

13:42

Dec17

Actus Biotechs Chief Medical Officer Sells Company Common Stock

22:54

Dec16

BTIG Analyst Reiterates Buy Rating for Arcutis Biotherapeutics

13:52

Nov26

Mizuho Securities Reiterates Buy Rating on Arcutis Biotherapeutics

21:57

Nov25

Arcutis Biotherapeutics Inc Director Lin Sue-Jean Sells and Exercises Options

23:31

Nov24

Akutsis Biotech CEO Disposes of Company Common Stock

23:46

Schedules & Filings

Schedules

Filings

Oct28

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 99.22 M, Net Income 7.41 M, EPS 0.058

Aug6

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 81.5 M, Net Income -15.89 M, EPS -0.125

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 65.85 M, Net Income -25.06 M, EPS -0.1988

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change